Study of Sequential CAR-T Cell Treating Leukemia Children

Clinical trial NCT04340154 · TERMINATED

Trial details

NCT number: NCT04340154
Sponsor: Beijing Boren Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, in Relapse Refractory Acute Lymphoid Leukemia

Start date: 2020-05-01
Primary completion: 2024-05-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.